T lymphocytes (CD3) may participate in the recurrence of cervical intraepithelial neoplasia grade III

• Published in: Archives of gynecology and obstetrics 2008-12, Vol.278 (6), p.525-530
• Main Authors: Maluf, P. J., Michelin, M. A., Etchebehere, R. M., Adad, S. J., Murta, E. F. C.
• Format: Article
• Language: English
• Subjects: Adult; B-Lymphocytes - enzymology; B-Lymphocytes - immunology; CD3 antigen; CD3 Complex - immunology; CD8-Positive T-Lymphocytes - enzymology; CD8-Positive T-Lymphocytes - immunology; Cervical Intraepithelial Neoplasia - enzymology; Cervical Intraepithelial Neoplasia - immunology; Cervical Intraepithelial Neoplasia - pathology; Cervical Intraepithelial Neoplasia - surgery; Endocrinology; Enzymes; Female; Follow-Up Studies; Gynecology; Human Genetics; Humans; Immunohistochemistry; Lymphocytes; Macrophages - enzymology; Macrophages - immunology; Medicine; Medicine & Public Health; Middle Aged; Neoplasm Recurrence, Local - immunology; Neoplasm Recurrence, Local - pathology; Nitric Oxide Synthase Type II - biosynthesis; Obstetrics/Perinatology/Midwifery; Original Article; T-Lymphocytes - enzymology; T-Lymphocytes - immunology; Uterine Cervical Neoplasms - enzymology; Uterine Cervical Neoplasms - immunology; Uterine Cervical Neoplasms - pathology; Uterine Cervical Neoplasms - surgery; Young Adult
• ISSN: 0932-0067; 1432-0711
• DOI: 10.1007/s00404-008-0621-8

Objective Data from the literature demonstrate that the local and systemic immune responses seem to play an important role in the progression of cervical intraepithelial neoplasia (CIN). Our aim was to investigate whether recurrences among CIN III patients might be related to the presence of local lymphocytes, macrophage and enzyme iNOS. Methods We analyzed 35 patients with CIN III who underwent conization and followed up for a minimum of 4 years. Using immunohistochemistry, the presence of T lymphocytes (CD3, CD8 and CD45RO), B lymphocytes (CD20), macrophages (CD68) and the expression of the enzyme iNOS were investigated. The quantity of marked cells is graded as: 0, absence of cells; 1, rare cells; 2, moderate number of cells; 3, many cells. For statistical purposes, we took the scores 0 and 1 to indicate weak marking and the scores 2 and 3 to indicate strong marking. Results We found strong positive expression of CD3-positive T lymphocytes among CIN III patients with recurrence following conization (100 vs. 50% without recurrence, p  = 0.02). We did not find any statistical differences in the expression of CD20, CD68, CD45RO, CD8 or iNOS. Conclusions It is concluded that strong positive findings of CD3 T lymphocytes were related to recurrence following conization due to CIN III.